TABLE 5.

Summary of malignancies in all reported SAE/SAR cases.

Malignancy Type/Location	All cases	Donor derived (DDC)	Donor transmitted P/P (DTC)	Total recipients from P/P donors	Total recipients with P/P Transmission a	Death from P/P Transmission b
RCC	43	16	2	5	2 (40%)	0 (0%)
Other malignancy	26	1	3	8	4 (50%)	3 (75%)
Adenocarcinoma	11	2	3	8	4 (50%)	3 (75%)
Urothelial carcinoma	9	6	2	8	2 (25%)	0 (0%)
Lung cancer	8	4	2	6	2 (33%)	1 (50%)
Lymphoma	5	0	2	5	4 (80%)	2 (50%)
Melanoma	2	0	2	4	4 (100%)	2 (50%)
Total	104	29	16	44	22 (50%)	11 (50%)

Abbreviations: DDC, donor-derived cancer; DTC, donor-transmitted cancer; RCC, renal cell carcinoma; P/P, proven/probable.

^a Recipients with transmission/all recipients from P/P donors.

^b Death from P/P transmission/all recipients with P/P transmission.